Office of Population Research, Princeton University, Princeton, New Jersey; the Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, California; Planned Parenthood Federation of America, New York, New York; and The Hull York Medical School, University of Hull, Hull, United Kingdom.
Corresponding author: Kelly Cleland, MPA, MPH, 218 Wallace Hall, Princeton University, Princeton, NJ 08648; e-mail: [email protected].
Supported in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development grant for Infrastructure for Population Research at Princeton University, grant R24HD047879 (J.T.).
The authors thank Mimi Tannen, NP, and Elizabeth Talmont, MSN, NP, of the Planned Parenthood Federation of America (PPFA) for their work related to the medical abortion adverse event reporting system and database.
Financial Disclosure Dr. Creinin receives compensation from Danco Laboratories, LLC, the distributor of mifepristone in the United States, for providing third-party telephone consults to clinicians who call for expert advice on mifepristone. The other authors did not report any potential conflicts of interest.
